Predictive Laboratories Announces Commercialization And Full Market Availability Of ARTguide™ At American Society Of Reproductive Medicine (ASRM) Scientific Congress And Expo
October 10, 2019 08:00 ET
|
Predictive Technology Group, Inc.
SALT LAKE CITY, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Predictive Laboratories, a wholly owned molecular and genetic diagnostics company of Predictive Technology Group (OTC Pink: PRED) focused on...
Predictive Technology Group Reports Fiscal Year 2019 Financial Results
September 30, 2019 16:02 ET
|
Predictive Technology Group, Inc.
SALT LAKE CITY, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED) (the Company), a leader in the use of data analytics for disease identification and subsequent...
Predictive Technology Group Accelerates Research Sample Collections to Support Development of Personalized Molecular Diagnostics and Clinical Therapies
August 20, 2019 09:15 ET
|
Predictive Technology Group, Inc.
SALT LAKE CITY, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent clinical...
Predictive Laboratories Announces Research Collaboration with the Preeclampsia Foundation
July 31, 2019 12:25 ET
|
Predictive Technology Group, Inc.
SALT LAKE CITY, July 31, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent precision...
Predictive Technology Group Announces the Presentation of New Data Demonstrating the Genetic Basis of Endometriosis at ESHRE
June 25, 2019 08:00 ET
|
Predictive Technology Group, Inc.
SALT LAKE CITY, June 25, 2019 (GLOBE NEWSWIRE) -- Predictive Laboratories, a wholly owned subsidiary of Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for...
Predictive Technology Group Announces the Presentation of New Genetic Findings in Endometriosis at the 35th Annual Meeting of the European Society of Human Reproduction and Embryology
June 20, 2019 08:00 ET
|
Predictive Technology Group, Inc.
SALT LAKE CITY, June 20, 2019 (GLOBE NEWSWIRE) -- Predictive Laboratories, a wholly owned subsidiary of Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for...
Predictive Biotech Signs Letter of Intent With IQVIA to Begin Clincial Trial for Osteoarthritis of the Knee
May 14, 2019 09:00 ET
|
Predictive Technology Group, Inc.
SALT LAKE CITY, May 14, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent precision...
Predictive Technology Group Finalizes Board Committee Chair Appointments
May 09, 2019 09:00 ET
|
Predictive Technology Group, Inc.
SALT LAKE CITY , May 09, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent clinical...
ObsEva SA Announces Initiation of Phase 3 EDELWEISS 2 and 3 Trials of Linzagolix for Endometriosis Associated Pain in U.S., Canada and Europe
May 09, 2019 01:00 ET
|
ObsEva SA
Geneva, Switzerland and Boston, MA – May 9, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel...
ObsEva SA Reports Consistent Long-Term Findings from Phase 2b EDELWEISS trial of Linzagolix for Endometriosis-Associated Pain
May 03, 2019 01:00 ET
|
ObsEva SA
Geneva, Switzerland and Boston, MA – May 3, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and...